Global Long-acting Hormone Injection Market Research Report 2025(Status and Outlook)
Report Overview
A long-acting hormone injection is a type of medication that is administered through an injection, designed to release hormones slowly over an extended period of time. This product typically contains a specific hormone, such as testosterone, estrogen, or growth hormone, which is encapsulated in a biodegradable or slow-release matrix. The primary purpose of a long-acting hormone injection is to maintain stable hormone levels in the body, which can be beneficial for various medical conditions, such as hormone replacement therapy, fertility treatments, or managing chronic illnesses. The slow release of the hormone allows for a more consistent and controlled delivery, reducing the need for frequent injections and potentially improving patient compliance. This product is usually prescribed by a healthcare professional and administered by a medical practitioner or trained individual, ensuring the correct dosage and minimizing the risk of adverse effects.
This report provides a deep insight into the global Long-acting Hormone Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long-acting Hormone Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long-acting Hormone Injection market in any manner.
Global Long-acting Hormone Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Bayer
Organon
Merck & Co. Inc.
Adare Pharma Solutions
Mylan NV
Novo Nordisk
Genentech
Eli Lily
Shree Venkatesh International Limited
LG Chem
Anhui Anke Biotechnology
Zhongshan Sinobioway Hygene Biomedicine
Shanghai United Cell Biotechnology
Changchun GeneScience Pharmaceutical
Market Segmentation (by Type)
Long-acting Contraceptive Injection
Growth Hormone Injection
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Long-acting Hormone Injection Market
Overview of the regional outlook of the Long-acting Hormone Injection Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting Hormone Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Long-acting Hormone Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
A long-acting hormone injection is a type of medication that is administered through an injection, designed to release hormones slowly over an extended period of time. This product typically contains a specific hormone, such as testosterone, estrogen, or growth hormone, which is encapsulated in a biodegradable or slow-release matrix. The primary purpose of a long-acting hormone injection is to maintain stable hormone levels in the body, which can be beneficial for various medical conditions, such as hormone replacement therapy, fertility treatments, or managing chronic illnesses. The slow release of the hormone allows for a more consistent and controlled delivery, reducing the need for frequent injections and potentially improving patient compliance. This product is usually prescribed by a healthcare professional and administered by a medical practitioner or trained individual, ensuring the correct dosage and minimizing the risk of adverse effects.
This report provides a deep insight into the global Long-acting Hormone Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long-acting Hormone Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long-acting Hormone Injection market in any manner.
Global Long-acting Hormone Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Bayer
Organon
Merck & Co. Inc.
Adare Pharma Solutions
Mylan NV
Novo Nordisk
Genentech
Eli Lily
Shree Venkatesh International Limited
LG Chem
Anhui Anke Biotechnology
Zhongshan Sinobioway Hygene Biomedicine
Shanghai United Cell Biotechnology
Changchun GeneScience Pharmaceutical
Market Segmentation (by Type)
Long-acting Contraceptive Injection
Growth Hormone Injection
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Long-acting Hormone Injection Market
Overview of the regional outlook of the Long-acting Hormone Injection Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting Hormone Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Long-acting Hormone Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Long-acting Hormone Injection
1.2 Key Market Segments
1.2.1 Long-acting Hormone Injection Segment by Type
1.2.2 Long-acting Hormone Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG-ACTING HORMONE INJECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long-acting Hormone Injection Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Long-acting Hormone Injection Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG-ACTING HORMONE INJECTION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Long-acting Hormone Injection Product Life Cycle
3.3 Global Long-acting Hormone Injection Sales by Manufacturers (2020-2025)
3.4 Global Long-acting Hormone Injection Revenue Market Share by Manufacturers (2020-2025)
3.5 Long-acting Hormone Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Long-acting Hormone Injection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Long-acting Hormone Injection Market Competitive Situation and Trends
3.8.1 Long-acting Hormone Injection Market Concentration Rate
3.8.2 Global 5 and 10 Largest Long-acting Hormone Injection Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LONG-ACTING HORMONE INJECTION INDUSTRY CHAIN ANALYSIS
4.1 Long-acting Hormone Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG-ACTING HORMONE INJECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Long-acting Hormone Injection Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Long-acting Hormone Injection Market
5.7 ESG Ratings of Leading Companies
6 LONG-ACTING HORMONE INJECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting Hormone Injection Sales Market Share by Type (2020-2025)
6.3 Global Long-acting Hormone Injection Market Size Market Share by Type (2020-2025)
6.4 Global Long-acting Hormone Injection Price by Type (2020-2025)
7 LONG-ACTING HORMONE INJECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting Hormone Injection Market Sales by Application (2020-2025)
7.3 Global Long-acting Hormone Injection Market Size (M USD) by Application (2020-2025)
7.4 Global Long-acting Hormone Injection Sales Growth Rate by Application (2020-2025)
8 LONG-ACTING HORMONE INJECTION MARKET SALES BY REGION
8.1 Global Long-acting Hormone Injection Sales by Region
8.1.1 Global Long-acting Hormone Injection Sales by Region
8.1.2 Global Long-acting Hormone Injection Sales Market Share by Region
8.2 Global Long-acting Hormone Injection Market Size by Region
8.2.1 Global Long-acting Hormone Injection Market Size by Region
8.2.2 Global Long-acting Hormone Injection Market Size Market Share by Region
8.3 North America
8.3.1 North America Long-acting Hormone Injection Sales by Country
8.3.2 North America Long-acting Hormone Injection Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Long-acting Hormone Injection Sales by Country
8.4.2 Europe Long-acting Hormone Injection Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Long-acting Hormone Injection Sales by Region
8.5.2 Asia Pacific Long-acting Hormone Injection Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Long-acting Hormone Injection Sales by Country
8.6.2 South America Long-acting Hormone Injection Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Long-acting Hormone Injection Sales by Region
8.7.2 Middle East and Africa Long-acting Hormone Injection Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LONG-ACTING HORMONE INJECTION MARKET PRODUCTION BY REGION
9.1 Global Production of Long-acting Hormone Injection by Region(2020-2025)
9.2 Global Long-acting Hormone Injection Revenue Market Share by Region (2020-2025)
9.3 Global Long-acting Hormone Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Long-acting Hormone Injection Production
9.4.1 North America Long-acting Hormone Injection Production Growth Rate (2020-2025)
9.4.2 North America Long-acting Hormone Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Long-acting Hormone Injection Production
9.5.1 Europe Long-acting Hormone Injection Production Growth Rate (2020-2025)
9.5.2 Europe Long-acting Hormone Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Long-acting Hormone Injection Production (2020-2025)
9.6.1 Japan Long-acting Hormone Injection Production Growth Rate (2020-2025)
9.6.2 Japan Long-acting Hormone Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Long-acting Hormone Injection Production (2020-2025)
9.7.1 China Long-acting Hormone Injection Production Growth Rate (2020-2025)
9.7.2 China Long-acting Hormone Injection Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Long-acting Hormone Injection Product Overview
10.1.3 Pfizer Long-acting Hormone Injection Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Bayer
10.2.1 Bayer Basic Information
10.2.2 Bayer Long-acting Hormone Injection Product Overview
10.2.3 Bayer Long-acting Hormone Injection Product Market Performance
10.2.4 Bayer Business Overview
10.2.5 Bayer SWOT Analysis
10.2.6 Bayer Recent Developments
10.3 Organon
10.3.1 Organon Basic Information
10.3.2 Organon Long-acting Hormone Injection Product Overview
10.3.3 Organon Long-acting Hormone Injection Product Market Performance
10.3.4 Organon Business Overview
10.3.5 Organon SWOT Analysis
10.3.6 Organon Recent Developments
10.4 Merck and Co. Inc.
10.4.1 Merck and Co. Inc. Basic Information
10.4.2 Merck and Co. Inc. Long-acting Hormone Injection Product Overview
10.4.3 Merck and Co. Inc. Long-acting Hormone Injection Product Market Performance
10.4.4 Merck and Co. Inc. Business Overview
10.4.5 Merck and Co. Inc. Recent Developments
10.5 Adare Pharma Solutions
10.5.1 Adare Pharma Solutions Basic Information
10.5.2 Adare Pharma Solutions Long-acting Hormone Injection Product Overview
10.5.3 Adare Pharma Solutions Long-acting Hormone Injection Product Market Performance
10.5.4 Adare Pharma Solutions Business Overview
10.5.5 Adare Pharma Solutions Recent Developments
10.6 Mylan NV
10.6.1 Mylan NV Basic Information
10.6.2 Mylan NV Long-acting Hormone Injection Product Overview
10.6.3 Mylan NV Long-acting Hormone Injection Product Market Performance
10.6.4 Mylan NV Business Overview
10.6.5 Mylan NV Recent Developments
10.7 Novo Nordisk
10.7.1 Novo Nordisk Basic Information
10.7.2 Novo Nordisk Long-acting Hormone Injection Product Overview
10.7.3 Novo Nordisk Long-acting Hormone Injection Product Market Performance
10.7.4 Novo Nordisk Business Overview
10.7.5 Novo Nordisk Recent Developments
10.8 Genentech
10.8.1 Genentech Basic Information
10.8.2 Genentech Long-acting Hormone Injection Product Overview
10.8.3 Genentech Long-acting Hormone Injection Product Market Performance
10.8.4 Genentech Business Overview
10.8.5 Genentech Recent Developments
10.9 Eli Lily
10.9.1 Eli Lily Basic Information
10.9.2 Eli Lily Long-acting Hormone Injection Product Overview
10.9.3 Eli Lily Long-acting Hormone Injection Product Market Performance
10.9.4 Eli Lily Business Overview
10.9.5 Eli Lily Recent Developments
10.10 Shree Venkatesh International Limited
10.10.1 Shree Venkatesh International Limited Basic Information
10.10.2 Shree Venkatesh International Limited Long-acting Hormone Injection Product Overview
10.10.3 Shree Venkatesh International Limited Long-acting Hormone Injection Product Market Performance
10.10.4 Shree Venkatesh International Limited Business Overview
10.10.5 Shree Venkatesh International Limited Recent Developments
10.11 LG Chem
10.11.1 LG Chem Basic Information
10.11.2 LG Chem Long-acting Hormone Injection Product Overview
10.11.3 LG Chem Long-acting Hormone Injection Product Market Performance
10.11.4 LG Chem Business Overview
10.11.5 LG Chem Recent Developments
10.12 Anhui Anke Biotechnology
10.12.1 Anhui Anke Biotechnology Basic Information
10.12.2 Anhui Anke Biotechnology Long-acting Hormone Injection Product Overview
10.12.3 Anhui Anke Biotechnology Long-acting Hormone Injection Product Market Performance
10.12.4 Anhui Anke Biotechnology Business Overview
10.12.5 Anhui Anke Biotechnology Recent Developments
10.13 Zhongshan Sinobioway Hygene Biomedicine
10.13.1 Zhongshan Sinobioway Hygene Biomedicine Basic Information
10.13.2 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Overview
10.13.3 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Market Performance
10.13.4 Zhongshan Sinobioway Hygene Biomedicine Business Overview
10.13.5 Zhongshan Sinobioway Hygene Biomedicine Recent Developments
10.14 Shanghai United Cell Biotechnology
10.14.1 Shanghai United Cell Biotechnology Basic Information
10.14.2 Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Overview
10.14.3 Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Market Performance
10.14.4 Shanghai United Cell Biotechnology Business Overview
10.14.5 Shanghai United Cell Biotechnology Recent Developments
10.15 Changchun GeneScience Pharmaceutical
10.15.1 Changchun GeneScience Pharmaceutical Basic Information
10.15.2 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Overview
10.15.3 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Market Performance
10.15.4 Changchun GeneScience Pharmaceutical Business Overview
10.15.5 Changchun GeneScience Pharmaceutical Recent Developments
11 LONG-ACTING HORMONE INJECTION MARKET FORECAST BY REGION
11.1 Global Long-acting Hormone Injection Market Size Forecast
11.2 Global Long-acting Hormone Injection Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long-acting Hormone Injection Market Size Forecast by Country
11.2.3 Asia Pacific Long-acting Hormone Injection Market Size Forecast by Region
11.2.4 South America Long-acting Hormone Injection Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Long-acting Hormone Injection by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Long-acting Hormone Injection Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Long-acting Hormone Injection by Type (2026-2033)
12.1.2 Global Long-acting Hormone Injection Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Long-acting Hormone Injection by Type (2026-2033)
12.2 Global Long-acting Hormone Injection Market Forecast by Application (2026-2033)
12.2.1 Global Long-acting Hormone Injection Sales (K Units) Forecast by Application
12.2.2 Global Long-acting Hormone Injection Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Long-acting Hormone Injection
1.2 Key Market Segments
1.2.1 Long-acting Hormone Injection Segment by Type
1.2.2 Long-acting Hormone Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG-ACTING HORMONE INJECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long-acting Hormone Injection Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Long-acting Hormone Injection Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG-ACTING HORMONE INJECTION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Long-acting Hormone Injection Product Life Cycle
3.3 Global Long-acting Hormone Injection Sales by Manufacturers (2020-2025)
3.4 Global Long-acting Hormone Injection Revenue Market Share by Manufacturers (2020-2025)
3.5 Long-acting Hormone Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Long-acting Hormone Injection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Long-acting Hormone Injection Market Competitive Situation and Trends
3.8.1 Long-acting Hormone Injection Market Concentration Rate
3.8.2 Global 5 and 10 Largest Long-acting Hormone Injection Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LONG-ACTING HORMONE INJECTION INDUSTRY CHAIN ANALYSIS
4.1 Long-acting Hormone Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG-ACTING HORMONE INJECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Long-acting Hormone Injection Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Long-acting Hormone Injection Market
5.7 ESG Ratings of Leading Companies
6 LONG-ACTING HORMONE INJECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting Hormone Injection Sales Market Share by Type (2020-2025)
6.3 Global Long-acting Hormone Injection Market Size Market Share by Type (2020-2025)
6.4 Global Long-acting Hormone Injection Price by Type (2020-2025)
7 LONG-ACTING HORMONE INJECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting Hormone Injection Market Sales by Application (2020-2025)
7.3 Global Long-acting Hormone Injection Market Size (M USD) by Application (2020-2025)
7.4 Global Long-acting Hormone Injection Sales Growth Rate by Application (2020-2025)
8 LONG-ACTING HORMONE INJECTION MARKET SALES BY REGION
8.1 Global Long-acting Hormone Injection Sales by Region
8.1.1 Global Long-acting Hormone Injection Sales by Region
8.1.2 Global Long-acting Hormone Injection Sales Market Share by Region
8.2 Global Long-acting Hormone Injection Market Size by Region
8.2.1 Global Long-acting Hormone Injection Market Size by Region
8.2.2 Global Long-acting Hormone Injection Market Size Market Share by Region
8.3 North America
8.3.1 North America Long-acting Hormone Injection Sales by Country
8.3.2 North America Long-acting Hormone Injection Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Long-acting Hormone Injection Sales by Country
8.4.2 Europe Long-acting Hormone Injection Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Long-acting Hormone Injection Sales by Region
8.5.2 Asia Pacific Long-acting Hormone Injection Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Long-acting Hormone Injection Sales by Country
8.6.2 South America Long-acting Hormone Injection Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Long-acting Hormone Injection Sales by Region
8.7.2 Middle East and Africa Long-acting Hormone Injection Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LONG-ACTING HORMONE INJECTION MARKET PRODUCTION BY REGION
9.1 Global Production of Long-acting Hormone Injection by Region(2020-2025)
9.2 Global Long-acting Hormone Injection Revenue Market Share by Region (2020-2025)
9.3 Global Long-acting Hormone Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Long-acting Hormone Injection Production
9.4.1 North America Long-acting Hormone Injection Production Growth Rate (2020-2025)
9.4.2 North America Long-acting Hormone Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Long-acting Hormone Injection Production
9.5.1 Europe Long-acting Hormone Injection Production Growth Rate (2020-2025)
9.5.2 Europe Long-acting Hormone Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Long-acting Hormone Injection Production (2020-2025)
9.6.1 Japan Long-acting Hormone Injection Production Growth Rate (2020-2025)
9.6.2 Japan Long-acting Hormone Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Long-acting Hormone Injection Production (2020-2025)
9.7.1 China Long-acting Hormone Injection Production Growth Rate (2020-2025)
9.7.2 China Long-acting Hormone Injection Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Long-acting Hormone Injection Product Overview
10.1.3 Pfizer Long-acting Hormone Injection Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Bayer
10.2.1 Bayer Basic Information
10.2.2 Bayer Long-acting Hormone Injection Product Overview
10.2.3 Bayer Long-acting Hormone Injection Product Market Performance
10.2.4 Bayer Business Overview
10.2.5 Bayer SWOT Analysis
10.2.6 Bayer Recent Developments
10.3 Organon
10.3.1 Organon Basic Information
10.3.2 Organon Long-acting Hormone Injection Product Overview
10.3.3 Organon Long-acting Hormone Injection Product Market Performance
10.3.4 Organon Business Overview
10.3.5 Organon SWOT Analysis
10.3.6 Organon Recent Developments
10.4 Merck and Co. Inc.
10.4.1 Merck and Co. Inc. Basic Information
10.4.2 Merck and Co. Inc. Long-acting Hormone Injection Product Overview
10.4.3 Merck and Co. Inc. Long-acting Hormone Injection Product Market Performance
10.4.4 Merck and Co. Inc. Business Overview
10.4.5 Merck and Co. Inc. Recent Developments
10.5 Adare Pharma Solutions
10.5.1 Adare Pharma Solutions Basic Information
10.5.2 Adare Pharma Solutions Long-acting Hormone Injection Product Overview
10.5.3 Adare Pharma Solutions Long-acting Hormone Injection Product Market Performance
10.5.4 Adare Pharma Solutions Business Overview
10.5.5 Adare Pharma Solutions Recent Developments
10.6 Mylan NV
10.6.1 Mylan NV Basic Information
10.6.2 Mylan NV Long-acting Hormone Injection Product Overview
10.6.3 Mylan NV Long-acting Hormone Injection Product Market Performance
10.6.4 Mylan NV Business Overview
10.6.5 Mylan NV Recent Developments
10.7 Novo Nordisk
10.7.1 Novo Nordisk Basic Information
10.7.2 Novo Nordisk Long-acting Hormone Injection Product Overview
10.7.3 Novo Nordisk Long-acting Hormone Injection Product Market Performance
10.7.4 Novo Nordisk Business Overview
10.7.5 Novo Nordisk Recent Developments
10.8 Genentech
10.8.1 Genentech Basic Information
10.8.2 Genentech Long-acting Hormone Injection Product Overview
10.8.3 Genentech Long-acting Hormone Injection Product Market Performance
10.8.4 Genentech Business Overview
10.8.5 Genentech Recent Developments
10.9 Eli Lily
10.9.1 Eli Lily Basic Information
10.9.2 Eli Lily Long-acting Hormone Injection Product Overview
10.9.3 Eli Lily Long-acting Hormone Injection Product Market Performance
10.9.4 Eli Lily Business Overview
10.9.5 Eli Lily Recent Developments
10.10 Shree Venkatesh International Limited
10.10.1 Shree Venkatesh International Limited Basic Information
10.10.2 Shree Venkatesh International Limited Long-acting Hormone Injection Product Overview
10.10.3 Shree Venkatesh International Limited Long-acting Hormone Injection Product Market Performance
10.10.4 Shree Venkatesh International Limited Business Overview
10.10.5 Shree Venkatesh International Limited Recent Developments
10.11 LG Chem
10.11.1 LG Chem Basic Information
10.11.2 LG Chem Long-acting Hormone Injection Product Overview
10.11.3 LG Chem Long-acting Hormone Injection Product Market Performance
10.11.4 LG Chem Business Overview
10.11.5 LG Chem Recent Developments
10.12 Anhui Anke Biotechnology
10.12.1 Anhui Anke Biotechnology Basic Information
10.12.2 Anhui Anke Biotechnology Long-acting Hormone Injection Product Overview
10.12.3 Anhui Anke Biotechnology Long-acting Hormone Injection Product Market Performance
10.12.4 Anhui Anke Biotechnology Business Overview
10.12.5 Anhui Anke Biotechnology Recent Developments
10.13 Zhongshan Sinobioway Hygene Biomedicine
10.13.1 Zhongshan Sinobioway Hygene Biomedicine Basic Information
10.13.2 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Overview
10.13.3 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Market Performance
10.13.4 Zhongshan Sinobioway Hygene Biomedicine Business Overview
10.13.5 Zhongshan Sinobioway Hygene Biomedicine Recent Developments
10.14 Shanghai United Cell Biotechnology
10.14.1 Shanghai United Cell Biotechnology Basic Information
10.14.2 Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Overview
10.14.3 Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Market Performance
10.14.4 Shanghai United Cell Biotechnology Business Overview
10.14.5 Shanghai United Cell Biotechnology Recent Developments
10.15 Changchun GeneScience Pharmaceutical
10.15.1 Changchun GeneScience Pharmaceutical Basic Information
10.15.2 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Overview
10.15.3 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Market Performance
10.15.4 Changchun GeneScience Pharmaceutical Business Overview
10.15.5 Changchun GeneScience Pharmaceutical Recent Developments
11 LONG-ACTING HORMONE INJECTION MARKET FORECAST BY REGION
11.1 Global Long-acting Hormone Injection Market Size Forecast
11.2 Global Long-acting Hormone Injection Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long-acting Hormone Injection Market Size Forecast by Country
11.2.3 Asia Pacific Long-acting Hormone Injection Market Size Forecast by Region
11.2.4 South America Long-acting Hormone Injection Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Long-acting Hormone Injection by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Long-acting Hormone Injection Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Long-acting Hormone Injection by Type (2026-2033)
12.1.2 Global Long-acting Hormone Injection Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Long-acting Hormone Injection by Type (2026-2033)
12.2 Global Long-acting Hormone Injection Market Forecast by Application (2026-2033)
12.2.1 Global Long-acting Hormone Injection Sales (K Units) Forecast by Application
12.2.2 Global Long-acting Hormone Injection Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long-acting Hormone Injection Market Size Comparison by Region (M USD)
Table 5. Global Long-acting Hormone Injection Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Long-acting Hormone Injection Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Long-acting Hormone Injection Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Long-acting Hormone Injection Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Hormone Injection as of 2024)
Table 10. Global Market Long-acting Hormone Injection Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Long-acting Hormone Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Long-acting Hormone Injection Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Long-acting Hormone Injection Sales by Type (K Units)
Table 26. Global Long-acting Hormone Injection Market Size by Type (M USD)
Table 27. Global Long-acting Hormone Injection Sales (K Units) by Type (2020-2025)
Table 28. Global Long-acting Hormone Injection Sales Market Share by Type (2020-2025)
Table 29. Global Long-acting Hormone Injection Market Size (M USD) by Type (2020-2025)
Table 30. Global Long-acting Hormone Injection Market Size Share by Type (2020-2025)
Table 31. Global Long-acting Hormone Injection Price (USD/Unit) by Type (2020-2025)
Table 32. Global Long-acting Hormone Injection Sales (K Units) by Application
Table 33. Global Long-acting Hormone Injection Market Size by Application
Table 34. Global Long-acting Hormone Injection Sales by Application (2020-2025) & (K Units)
Table 35. Global Long-acting Hormone Injection Sales Market Share by Application (2020-2025)
Table 36. Global Long-acting Hormone Injection Market Size by Application (2020-2025) & (M USD)
Table 37. Global Long-acting Hormone Injection Market Share by Application (2020-2025)
Table 38. Global Long-acting Hormone Injection Sales Growth Rate by Application (2020-2025)
Table 39. Global Long-acting Hormone Injection Sales by Region (2020-2025) & (K Units)
Table 40. Global Long-acting Hormone Injection Sales Market Share by Region (2020-2025)
Table 41. Global Long-acting Hormone Injection Market Size by Region (2020-2025) & (M USD)
Table 42. Global Long-acting Hormone Injection Market Size Market Share by Region (2020-2025)
Table 43. North America Long-acting Hormone Injection Sales by Country (2020-2025) & (K Units)
Table 44. North America Long-acting Hormone Injection Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Long-acting Hormone Injection Sales by Country (2020-2025) & (K Units)
Table 46. Europe Long-acting Hormone Injection Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Long-acting Hormone Injection Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Long-acting Hormone Injection Market Size by Region (2020-2025) & (M USD)
Table 49. South America Long-acting Hormone Injection Sales by Country (2020-2025) & (K Units)
Table 50. South America Long-acting Hormone Injection Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Long-acting Hormone Injection Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Long-acting Hormone Injection Market Size by Region (2020-2025) & (M USD)
Table 53. Global Long-acting Hormone Injection Production (K Units) by Region(2020-2025)
Table 54. Global Long-acting Hormone Injection Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Long-acting Hormone Injection Revenue Market Share by Region (2020-2025)
Table 56. Global Long-acting Hormone Injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Long-acting Hormone Injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Long-acting Hormone Injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Long-acting Hormone Injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Long-acting Hormone Injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Pfizer Basic Information
Table 62. Pfizer Long-acting Hormone Injection Product Overview
Table 63. Pfizer Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pfizer Business Overview
Table 65. Pfizer SWOT Analysis
Table 66. Pfizer Recent Developments
Table 67. Bayer Basic Information
Table 68. Bayer Long-acting Hormone Injection Product Overview
Table 69. Bayer Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Bayer Business Overview
Table 71. Bayer SWOT Analysis
Table 72. Bayer Recent Developments
Table 73. Organon Basic Information
Table 74. Organon Long-acting Hormone Injection Product Overview
Table 75. Organon Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Organon Business Overview
Table 77. Organon SWOT Analysis
Table 78. Organon Recent Developments
Table 79. Merck and Co. Inc. Basic Information
Table 80. Merck and Co. Inc. Long-acting Hormone Injection Product Overview
Table 81. Merck and Co. Inc. Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Merck and Co. Inc. Business Overview
Table 83. Merck and Co. Inc. Recent Developments
Table 84. Adare Pharma Solutions Basic Information
Table 85. Adare Pharma Solutions Long-acting Hormone Injection Product Overview
Table 86. Adare Pharma Solutions Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Adare Pharma Solutions Business Overview
Table 88. Adare Pharma Solutions Recent Developments
Table 89. Mylan NV Basic Information
Table 90. Mylan NV Long-acting Hormone Injection Product Overview
Table 91. Mylan NV Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Mylan NV Business Overview
Table 93. Mylan NV Recent Developments
Table 94. Novo Nordisk Basic Information
Table 95. Novo Nordisk Long-acting Hormone Injection Product Overview
Table 96. Novo Nordisk Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Novo Nordisk Business Overview
Table 98. Novo Nordisk Recent Developments
Table 99. Genentech Basic Information
Table 100. Genentech Long-acting Hormone Injection Product Overview
Table 101. Genentech Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Genentech Business Overview
Table 103. Genentech Recent Developments
Table 104. Eli Lily Basic Information
Table 105. Eli Lily Long-acting Hormone Injection Product Overview
Table 106. Eli Lily Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Eli Lily Business Overview
Table 108. Eli Lily Recent Developments
Table 109. Shree Venkatesh International Limited Basic Information
Table 110. Shree Venkatesh International Limited Long-acting Hormone Injection Product Overview
Table 111. Shree Venkatesh International Limited Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Shree Venkatesh International Limited Business Overview
Table 113. Shree Venkatesh International Limited Recent Developments
Table 114. LG Chem Basic Information
Table 115. LG Chem Long-acting Hormone Injection Product Overview
Table 116. LG Chem Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. LG Chem Business Overview
Table 118. LG Chem Recent Developments
Table 119. Anhui Anke Biotechnology Basic Information
Table 120. Anhui Anke Biotechnology Long-acting Hormone Injection Product Overview
Table 121. Anhui Anke Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Anhui Anke Biotechnology Business Overview
Table 123. Anhui Anke Biotechnology Recent Developments
Table 124. Zhongshan Sinobioway Hygene Biomedicine Basic Information
Table 125. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Overview
Table 126. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Zhongshan Sinobioway Hygene Biomedicine Business Overview
Table 128. Zhongshan Sinobioway Hygene Biomedicine Recent Developments
Table 129. Shanghai United Cell Biotechnology Basic Information
Table 130. Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Overview
Table 131. Shanghai United Cell Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Shanghai United Cell Biotechnology Business Overview
Table 133. Shanghai United Cell Biotechnology Recent Developments
Table 134. Changchun GeneScience Pharmaceutical Basic Information
Table 135. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Overview
Table 136. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Changchun GeneScience Pharmaceutical Business Overview
Table 138. Changchun GeneScience Pharmaceutical Recent Developments
Table 139. Global Long-acting Hormone Injection Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Long-acting Hormone Injection Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Long-acting Hormone Injection Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Long-acting Hormone Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Long-acting Hormone Injection Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Long-acting Hormone Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Long-acting Hormone Injection Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Long-acting Hormone Injection Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Long-acting Hormone Injection Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Long-acting Hormone Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Long-acting Hormone Injection Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Long-acting Hormone Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Long-acting Hormone Injection Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Long-acting Hormone Injection Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Long-acting Hormone Injection Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Long-acting Hormone Injection Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Long-acting Hormone Injection Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long-acting Hormone Injection Market Size Comparison by Region (M USD)
Table 5. Global Long-acting Hormone Injection Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Long-acting Hormone Injection Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Long-acting Hormone Injection Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Long-acting Hormone Injection Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Hormone Injection as of 2024)
Table 10. Global Market Long-acting Hormone Injection Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Long-acting Hormone Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Long-acting Hormone Injection Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Long-acting Hormone Injection Sales by Type (K Units)
Table 26. Global Long-acting Hormone Injection Market Size by Type (M USD)
Table 27. Global Long-acting Hormone Injection Sales (K Units) by Type (2020-2025)
Table 28. Global Long-acting Hormone Injection Sales Market Share by Type (2020-2025)
Table 29. Global Long-acting Hormone Injection Market Size (M USD) by Type (2020-2025)
Table 30. Global Long-acting Hormone Injection Market Size Share by Type (2020-2025)
Table 31. Global Long-acting Hormone Injection Price (USD/Unit) by Type (2020-2025)
Table 32. Global Long-acting Hormone Injection Sales (K Units) by Application
Table 33. Global Long-acting Hormone Injection Market Size by Application
Table 34. Global Long-acting Hormone Injection Sales by Application (2020-2025) & (K Units)
Table 35. Global Long-acting Hormone Injection Sales Market Share by Application (2020-2025)
Table 36. Global Long-acting Hormone Injection Market Size by Application (2020-2025) & (M USD)
Table 37. Global Long-acting Hormone Injection Market Share by Application (2020-2025)
Table 38. Global Long-acting Hormone Injection Sales Growth Rate by Application (2020-2025)
Table 39. Global Long-acting Hormone Injection Sales by Region (2020-2025) & (K Units)
Table 40. Global Long-acting Hormone Injection Sales Market Share by Region (2020-2025)
Table 41. Global Long-acting Hormone Injection Market Size by Region (2020-2025) & (M USD)
Table 42. Global Long-acting Hormone Injection Market Size Market Share by Region (2020-2025)
Table 43. North America Long-acting Hormone Injection Sales by Country (2020-2025) & (K Units)
Table 44. North America Long-acting Hormone Injection Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Long-acting Hormone Injection Sales by Country (2020-2025) & (K Units)
Table 46. Europe Long-acting Hormone Injection Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Long-acting Hormone Injection Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Long-acting Hormone Injection Market Size by Region (2020-2025) & (M USD)
Table 49. South America Long-acting Hormone Injection Sales by Country (2020-2025) & (K Units)
Table 50. South America Long-acting Hormone Injection Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Long-acting Hormone Injection Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Long-acting Hormone Injection Market Size by Region (2020-2025) & (M USD)
Table 53. Global Long-acting Hormone Injection Production (K Units) by Region(2020-2025)
Table 54. Global Long-acting Hormone Injection Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Long-acting Hormone Injection Revenue Market Share by Region (2020-2025)
Table 56. Global Long-acting Hormone Injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Long-acting Hormone Injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Long-acting Hormone Injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Long-acting Hormone Injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Long-acting Hormone Injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Pfizer Basic Information
Table 62. Pfizer Long-acting Hormone Injection Product Overview
Table 63. Pfizer Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pfizer Business Overview
Table 65. Pfizer SWOT Analysis
Table 66. Pfizer Recent Developments
Table 67. Bayer Basic Information
Table 68. Bayer Long-acting Hormone Injection Product Overview
Table 69. Bayer Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Bayer Business Overview
Table 71. Bayer SWOT Analysis
Table 72. Bayer Recent Developments
Table 73. Organon Basic Information
Table 74. Organon Long-acting Hormone Injection Product Overview
Table 75. Organon Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Organon Business Overview
Table 77. Organon SWOT Analysis
Table 78. Organon Recent Developments
Table 79. Merck and Co. Inc. Basic Information
Table 80. Merck and Co. Inc. Long-acting Hormone Injection Product Overview
Table 81. Merck and Co. Inc. Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Merck and Co. Inc. Business Overview
Table 83. Merck and Co. Inc. Recent Developments
Table 84. Adare Pharma Solutions Basic Information
Table 85. Adare Pharma Solutions Long-acting Hormone Injection Product Overview
Table 86. Adare Pharma Solutions Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Adare Pharma Solutions Business Overview
Table 88. Adare Pharma Solutions Recent Developments
Table 89. Mylan NV Basic Information
Table 90. Mylan NV Long-acting Hormone Injection Product Overview
Table 91. Mylan NV Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Mylan NV Business Overview
Table 93. Mylan NV Recent Developments
Table 94. Novo Nordisk Basic Information
Table 95. Novo Nordisk Long-acting Hormone Injection Product Overview
Table 96. Novo Nordisk Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Novo Nordisk Business Overview
Table 98. Novo Nordisk Recent Developments
Table 99. Genentech Basic Information
Table 100. Genentech Long-acting Hormone Injection Product Overview
Table 101. Genentech Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Genentech Business Overview
Table 103. Genentech Recent Developments
Table 104. Eli Lily Basic Information
Table 105. Eli Lily Long-acting Hormone Injection Product Overview
Table 106. Eli Lily Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Eli Lily Business Overview
Table 108. Eli Lily Recent Developments
Table 109. Shree Venkatesh International Limited Basic Information
Table 110. Shree Venkatesh International Limited Long-acting Hormone Injection Product Overview
Table 111. Shree Venkatesh International Limited Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Shree Venkatesh International Limited Business Overview
Table 113. Shree Venkatesh International Limited Recent Developments
Table 114. LG Chem Basic Information
Table 115. LG Chem Long-acting Hormone Injection Product Overview
Table 116. LG Chem Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. LG Chem Business Overview
Table 118. LG Chem Recent Developments
Table 119. Anhui Anke Biotechnology Basic Information
Table 120. Anhui Anke Biotechnology Long-acting Hormone Injection Product Overview
Table 121. Anhui Anke Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Anhui Anke Biotechnology Business Overview
Table 123. Anhui Anke Biotechnology Recent Developments
Table 124. Zhongshan Sinobioway Hygene Biomedicine Basic Information
Table 125. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Overview
Table 126. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Zhongshan Sinobioway Hygene Biomedicine Business Overview
Table 128. Zhongshan Sinobioway Hygene Biomedicine Recent Developments
Table 129. Shanghai United Cell Biotechnology Basic Information
Table 130. Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Overview
Table 131. Shanghai United Cell Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Shanghai United Cell Biotechnology Business Overview
Table 133. Shanghai United Cell Biotechnology Recent Developments
Table 134. Changchun GeneScience Pharmaceutical Basic Information
Table 135. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Overview
Table 136. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Changchun GeneScience Pharmaceutical Business Overview
Table 138. Changchun GeneScience Pharmaceutical Recent Developments
Table 139. Global Long-acting Hormone Injection Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Long-acting Hormone Injection Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Long-acting Hormone Injection Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Long-acting Hormone Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Long-acting Hormone Injection Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Long-acting Hormone Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Long-acting Hormone Injection Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Long-acting Hormone Injection Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Long-acting Hormone Injection Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Long-acting Hormone Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Long-acting Hormone Injection Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Long-acting Hormone Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Long-acting Hormone Injection Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Long-acting Hormone Injection Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Long-acting Hormone Injection Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Long-acting Hormone Injection Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Long-acting Hormone Injection Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Long-acting Hormone Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting Hormone Injection Market Size (M USD), 2024-2033
Figure 5. Global Long-acting Hormone Injection Market Size (M USD) (2020-2033)
Figure 6. Global Long-acting Hormone Injection Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting Hormone Injection Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Long-acting Hormone Injection Product Life Cycle
Figure 13. Long-acting Hormone Injection Sales Share by Manufacturers in 2024
Figure 14. Global Long-acting Hormone Injection Revenue Share by Manufacturers in 2024
Figure 15. Long-acting Hormone Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Long-acting Hormone Injection Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Long-acting Hormone Injection Revenue in 2024
Figure 18. Industry Chain Map of Long-acting Hormone Injection
Figure 19. Global Long-acting Hormone Injection Market PEST Analysis
Figure 20. Global Long-acting Hormone Injection Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Long-acting Hormone Injection Market Share by Type
Figure 27. Sales Market Share of Long-acting Hormone Injection by Type (2020-2025)
Figure 28. Sales Market Share of Long-acting Hormone Injection by Type in 2024
Figure 29. Market Size Share of Long-acting Hormone Injection by Type (2020-2025)
Figure 30. Market Size Share of Long-acting Hormone Injection by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Long-acting Hormone Injection Market Share by Application
Figure 33. Global Long-acting Hormone Injection Sales Market Share by Application (2020-2025)
Figure 34. Global Long-acting Hormone Injection Sales Market Share by Application in 2024
Figure 35. Global Long-acting Hormone Injection Market Share by Application (2020-2025)
Figure 36. Global Long-acting Hormone Injection Market Share by Application in 2024
Figure 37. Global Long-acting Hormone Injection Sales Growth Rate by Application (2020-2025)
Figure 38. Global Long-acting Hormone Injection Sales Market Share by Region (2020-2025)
Figure 39. Global Long-acting Hormone Injection Market Size Market Share by Region (2020-2025)
Figure 40. North America Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Long-acting Hormone Injection Sales Market Share by Country in 2024
Figure 43. North America Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Long-acting Hormone Injection Market Size Market Share by Country in 2024
Figure 45. U.S. Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Long-acting Hormone Injection Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Long-acting Hormone Injection Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Long-acting Hormone Injection Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Long-acting Hormone Injection Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Long-acting Hormone Injection Sales Market Share by Country in 2024
Figure 53. Europe Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Long-acting Hormone Injection Market Size Market Share by Country in 2024
Figure 55. Germany Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Long-acting Hormone Injection Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Long-acting Hormone Injection Sales Market Share by Region in 2024
Figure 67. Asia Pacific Long-acting Hormone Injection Market Size Market Share by Region in 2024
Figure 68. China Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Long-acting Hormone Injection Sales and Growth Rate (K Units)
Figure 79. South America Long-acting Hormone Injection Sales Market Share by Country in 2024
Figure 80. South America Long-acting Hormone Injection Market Size and Growth Rate (M USD)
Figure 81. South America Long-acting Hormone Injection Market Size Market Share by Country in 2024
Figure 82. Brazil Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Long-acting Hormone Injection Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Long-acting Hormone Injection Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Long-acting Hormone Injection Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Long-acting Hormone Injection Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Long-acting Hormone Injection Production Market Share by Region (2020-2025)
Figure 103. North America Long-acting Hormone Injection Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Long-acting Hormone Injection Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Long-acting Hormone Injection Production (K Units) Growth Rate (2020-2025)
Figure 106. China Long-acting Hormone Injection Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Long-acting Hormone Injection Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Long-acting Hormone Injection Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Long-acting Hormone Injection Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Long-acting Hormone Injection Market Share Forecast by Type (2026-2033)
Figure 111. Global Long-acting Hormone Injection Sales Forecast by Application (2026-2033)
Figure 112. Global Long-acting Hormone Injection Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Long-acting Hormone Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting Hormone Injection Market Size (M USD), 2024-2033
Figure 5. Global Long-acting Hormone Injection Market Size (M USD) (2020-2033)
Figure 6. Global Long-acting Hormone Injection Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting Hormone Injection Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Long-acting Hormone Injection Product Life Cycle
Figure 13. Long-acting Hormone Injection Sales Share by Manufacturers in 2024
Figure 14. Global Long-acting Hormone Injection Revenue Share by Manufacturers in 2024
Figure 15. Long-acting Hormone Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Long-acting Hormone Injection Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Long-acting Hormone Injection Revenue in 2024
Figure 18. Industry Chain Map of Long-acting Hormone Injection
Figure 19. Global Long-acting Hormone Injection Market PEST Analysis
Figure 20. Global Long-acting Hormone Injection Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Long-acting Hormone Injection Market Share by Type
Figure 27. Sales Market Share of Long-acting Hormone Injection by Type (2020-2025)
Figure 28. Sales Market Share of Long-acting Hormone Injection by Type in 2024
Figure 29. Market Size Share of Long-acting Hormone Injection by Type (2020-2025)
Figure 30. Market Size Share of Long-acting Hormone Injection by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Long-acting Hormone Injection Market Share by Application
Figure 33. Global Long-acting Hormone Injection Sales Market Share by Application (2020-2025)
Figure 34. Global Long-acting Hormone Injection Sales Market Share by Application in 2024
Figure 35. Global Long-acting Hormone Injection Market Share by Application (2020-2025)
Figure 36. Global Long-acting Hormone Injection Market Share by Application in 2024
Figure 37. Global Long-acting Hormone Injection Sales Growth Rate by Application (2020-2025)
Figure 38. Global Long-acting Hormone Injection Sales Market Share by Region (2020-2025)
Figure 39. Global Long-acting Hormone Injection Market Size Market Share by Region (2020-2025)
Figure 40. North America Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Long-acting Hormone Injection Sales Market Share by Country in 2024
Figure 43. North America Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Long-acting Hormone Injection Market Size Market Share by Country in 2024
Figure 45. U.S. Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Long-acting Hormone Injection Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Long-acting Hormone Injection Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Long-acting Hormone Injection Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Long-acting Hormone Injection Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Long-acting Hormone Injection Sales Market Share by Country in 2024
Figure 53. Europe Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Long-acting Hormone Injection Market Size Market Share by Country in 2024
Figure 55. Germany Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Long-acting Hormone Injection Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Long-acting Hormone Injection Sales Market Share by Region in 2024
Figure 67. Asia Pacific Long-acting Hormone Injection Market Size Market Share by Region in 2024
Figure 68. China Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Long-acting Hormone Injection Sales and Growth Rate (K Units)
Figure 79. South America Long-acting Hormone Injection Sales Market Share by Country in 2024
Figure 80. South America Long-acting Hormone Injection Market Size and Growth Rate (M USD)
Figure 81. South America Long-acting Hormone Injection Market Size Market Share by Country in 2024
Figure 82. Brazil Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Long-acting Hormone Injection Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Long-acting Hormone Injection Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Long-acting Hormone Injection Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Long-acting Hormone Injection Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Long-acting Hormone Injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Long-acting Hormone Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Long-acting Hormone Injection Production Market Share by Region (2020-2025)
Figure 103. North America Long-acting Hormone Injection Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Long-acting Hormone Injection Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Long-acting Hormone Injection Production (K Units) Growth Rate (2020-2025)
Figure 106. China Long-acting Hormone Injection Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Long-acting Hormone Injection Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Long-acting Hormone Injection Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Long-acting Hormone Injection Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Long-acting Hormone Injection Market Share Forecast by Type (2026-2033)
Figure 111. Global Long-acting Hormone Injection Sales Forecast by Application (2026-2033)
Figure 112. Global Long-acting Hormone Injection Market Share Forecast by Application (2026-2033)
